Company: COHN
Filing Date: 2025-03-12
Form Type: 10-K
Source: 0001437749-25-007158
Chunk: 2214

Company: Cohen & Co Inc.
Filing Date: 2025-03-12
Form: 10-K
Item: Item 4
Chunk 2214
---
 OPTX) 

     (863
     )

     (1,141
     )

     278

      Tevogen Bio Holdings, Inc. (NASDAQ: TVGN) 

     (401
     )

     -

     (401
     )

      Zoomcar Holdings, Inc. (NASDAQ: ZCAR) 

     (7,097
     )

     (6
     )

     (7,091
     )

      CREO JV 

     617

     901

     (284
     )

      U.S. Insurance JV 

     (17
     )

     463

     (480
     )

      Stoa USA Inc./FlipOs 

     -

     (6,847
     )

     6,847

      SFAs 

     1,476

     25,395

     (23,919
     )

      Bridge loan 

     -

     1,050

     (1,050
     )

      Other 

     391

     (135
     )

     526

      Investing principal transactions 

     (10,240
     )

     19,261

     (29,501
     )

      Total principal transactions 

     (32,884
     )

     14,949

     (47,833
     )

      IIFC revenue share 

     2,557

     1,105

     1,452

      All other income 

     1,085

     400

     685

      Other income 

     3,642

     1,505

     2,137

      Total principal transactions and other income 
      
     $
     (29,242
     )
      
     $
     16,454

     $
     (45,696
     )

﻿ 

      46

Principal Transactions 

In the table above, our principal transactions are broken out into two groups:

1.  Capital Markets Principal Transactions: In some cases, CCM acquires financial instruments or receives financial instruments in lieu of cash for its advisory transactions. We carry these instruments at fair value with changes in fair value included as a component of principal transactions and other income in our consolidated income statement.  Gains and losses on these instruments are included in our Capital Markets segment as these instruments were acquired as part of CCM's activities.  See note 29 to our consolidated financial statements included in this Annual Report on Form 10-K.

2.